Published In
European Journal of Rheumatology
Volume 6 · Issue 1
Pages: 60-61
History
Published Online: September 3, 2019
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright © 2019 European Journal of Rheumatology
Muhammad K. Nisar
Department of Rheumatology, Luton & Dunstable University Hospital, Luton, United Kingdom
Nisar, M. K. (2019). Combining secukinumab and apremilast to successfully treat refractory psoriatic skin and joint disease: A novel approach. European Journal of Rheumatology, 6(1), 60–61. https://doi.org/10.5152/eurjrheum.2018.17188
Full Text
Full Text PDF
Full Text PDF
Abstract
Abstract
Cite this article as: Nisar MK. Combining secukinumab and apremilast to successfully treat refractory psoriatic skin and joint disease: a novel approach. Eur J Rheumatol 2019; 6(1): 57-8.
Article Info
Published In
Journal
European Journal of Rheumatology
Volume / Issue
Volume 6 · Issue 1
Pages
60-61
History
Published Online
September 3, 2019
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright
Copyright (c) 2019 European Journal of Rheumatology
Affiliations
Muhammad K. Nisar
Department of Rheumatology, Luton & Dunstable University Hospital, Luton, United Kingdom
Cite this Article
Nisar, M. K. (2019). Combining secukinumab and apremilast to successfully treat refractory psoriatic skin and joint disease: A novel approach. European Journal of Rheumatology, 6(1), 60–61. https://doi.org/10.5152/eurjrheum.2018.17188
Outlines